Deborah Weitzman, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 13,424 shares at $89.81 ($1.2M) on 2023-08-28, disclosed to the SEC on 2023-08-29.
Open-market sale of $1.2M CAH by CEO, Pharmaceutical Segment. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.81 | 6,712 | $603K | 50.0% |
| 2 | $89.81 | 6,712 | $603K | 50.0% |
| Total | $89.81 avg | 13,424 | $1.2M | 100% |
| Filing → |
| CAH | SELL | 2023-11-29 | $7.8M | — | Filing → |